Table 3.
Factors associated with ablation in AF patients with cancer.
| Variables | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|
| OR (95%CI) | P-value | OR (95%CI) | P-value | |
| Age | 0.92 (0.89–0.95) | <0.001 | 0.93 (0.90–0.96) | <0.001 |
| Hb | 1.01 (0.99–1.02) | 0.23 | ||
| PLT | 1.00 (1.00–1.01) | 0.20 | ||
| TSH | 0.91 (0.81–1.04) | 0.16 | ||
| LAD | 0.97 (0.92–1.02) | 0.21 | ||
| Male | 0.61 (0.38–0.97) | 0.037 | 0.68 (0.41–1.14) | 0.15 |
| HTN | 0.72 (0.45–1.15) | 0.17 | ||
| CHD | 0.48 (0.28–0.83) | 0.009 | 0.62 (0.35–1.12) | 0.11 |
| HF | 0.37 (0.20–0.68) | 0.001 | 0.62 (0.31–1.24) | 0.18 |
| DM | 0.56 (0.32–1.01) | 0.053 | ||
| Stroke | 0.55 (0.24–1.27) | 0.16 | ||
| CKD | 0.28 (0.11–0.73) | 0.009 | 0.37 (0.14–1.00) | 0.051 |
| PAD | 1.71 (0.15–19.09) | 0.66 | ||
| Active cancer | 0.92 (0.42–2.00) | 0.84 | ||
| surgery | 2.41 (0.83–7.02) | 0.11 | ||
| chemotherapy | 1.00 (0.48–2.12) | 0.99 | ||
| radiotherapy | 0.59 (0.17–2.05) | 0.41 | ||
| PeAF | 0.56 (0.34–0.91) | 0.02 | 0.75 (0.43–1.30) | 0.31 |
Abbreviations: see Table 1; CI, confidence interval; Hb, hemoglobin; OR, odds ratio; PLT, platelet.